Synthetic sialic-acid-containing polyvalent antiviral inhibitors

Medicinal Chemistry Research

Volumn 18, Issue 6, 2009, Pages 477-494

  Carlescu, Irina ^a   Scutaru, Dan ^a   Popa, Marcel ^a   Uglea, Constantin V ^b  

^a GHEORGHE ASACHI TECHNICAL UNIVERSITY OF IASI   (Romania)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Antiviral properties; Glycoconjugates; Influenza virus; Polyvalent synthetic inhibitors; Sialic acid

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; CHITOSAN; GLYCOPEPTIDE; INFLUENZA VACCINE; LIPOSOME; OSELTAMIVIR; POLY(4 NITROPHENYLACRYLATE); POLY(N ACRYLOYLOXYSUCCINIMIDE); POLYACRYLAMIDE; POLYACRYLIC ACID; POLYGLUTAMIC ACID; POLYMER; POLYSTYRENE; RIMANTADINE; SIALIC ACID; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

ANTIVIRAL ACTIVITY; BINDING AFFINITY; DRUG CONJUGATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FOOD AND DRUG ADMINISTRATION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PROPHYLAXIS; REVIEW; STRUCTURE ACTIVITY RELATION; UNSPECIFIED SIDE EFFECT; VIRUS INHIBITION;

EID: 67650766460     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-008-9139-7     Document Type: Review

References (92)

1. FN Al-Majhdi 2007 Structure of the sialic acid binding site in influenza a virus: hemagglutinin J Biol Sci 7 1 113 122 (Pubitemid 46957728)
2. WS Barclay IM Jones HMI Osborn L Phillipson J Ren GA Talevera CI Thompson 2007 Probing the receptor interactions of an H5 avian influenza virus using a baculovirus expression system and functionalised poly(acrylic acid) ligands Bioorg Med Chem 15 4038 4047 10.1016/j.bmc.2007.03.085
3. SG Baum J Carey 2007 Preventing and treating influenza J Respir Dis 28 1 21 29 (Pubitemid 46148469)
4. J Beigel M Bray 2008 Current and future antiviral therapy of severe seasonal and avian influenza Antiviral Res 78 1 91 102 10.1016/j.antiviral.2008. 01.003
5. RB Belshe B Burk F Newman RL Cerruti IS Sim 1989 Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance J Infect Dis 159 430 435 (Pubitemid 19065888)
6. NV Bovin 1998 Polyacrylamide-based glycoconjugates as tools in glycobiology Glycoconj J 15 431 446 10.1023/A:1006963717646
7. NV Bovin EY Korchagina TV Zemlyanukhina NE Byramova OE Galanina AE Zemlyakov AE Ivanov VP Zubov LV Mochalova 1993 Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides Glycoconj J 10 142 151 10.1007/BF00737711 (Pubitemid 23233227)
8. N Bovin A Tuzikov A Chinarev A Gambaryan 2004 Multimeric glycotherapeutics: new paradigm Glycoconj J 21 471 478 10.1007/s10719-004-5537-3
9. D Charych RC Stevens 1996 A 'litmus test' for molecular recognition using artificial membranes Chem Biol 3 113 120 10.1016/S1074-5521(96)90287-2 (Pubitemid 126682716)
10. Chinarev AA, Tuzikov AB, Gambarian AS, Matrosovich MN, Umberty A, Bovin NV (1999) Tetravalent blockers for influenza virus hemagglutinin. In: Inoue Y, Lee YC, Troy FA (eds) Sialobiology and other novel forms of glycosylation. Osaka, Japan Gakushin, pp 135-143
11. SK Choi M Mammen GM Whitesides 1996 Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups Chem Biol 3 97 104 10.1016/S1074-5521(96)90285-9
12. SK Choi M Mammen GM Whitesides 1997 Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination J Am Chem Soc 119 4103 4111 10.1021/ja963519x
13. PM Colman JN Varghese WG Laver 1983 Structure of the catalytic and antigenic site in influenza virus neuraminidase Nature 303 41 44 10.1038/303041a0
14. SJ Crennell EF Garman WG Laver ER Vimr GL Taylor 1993 Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase Proc Natl Acad Sci USA 90 9852 9856 10.1073/pnas.90.21.9852
15. RS Dave RJ Pomerantz 2003 RNA interference: on the road to an alternate therapeutic strategy! Rev Med Virol 13 6 373 385 10.1002/rmv.407
16. JC Dyason M von Itzstein 2001 Anti-influenza virus drug design: sialidase inhibitors Aust J Chem 54 663 670 10.1071/CH01173
17. AS Gambaryan AB Tuzikov VE Piskarev SS Yamnikova DK L'vov JC Robertson NV Bovin MN Matrosovich 1997 Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A, and influenza B viruses share a common high binding affinity for 6?-sialyl(N-acetllactosamine) Virology 233 224 234 10.1006/viro.1997.8580
18. AS Gambaryan JS Robertson MN Matrosovich 1999 Effects of eggs adaptation on the receptor binding properties of human influenza A and B viruses Virology 258 232 239 10.1006/viro.1999.9732
19. AS Gambaryan AB Tuzikov GV Pazynina RG Webster MN Matrosovich NV Bovin 2004 H5N1 chicken influenza viruses display a high binding affinity for Neu5Acα2-3Galß1-4(6-HSO3)GlcNAc-containing receptors Virology 326 2 310 316 10.1016/j.virol.2004.06.002
20. A Gamian M Chomik CA Laferriere R Roy 1991 Inhibition of influenza A virus hemagglutinin and induction of interferon by synthetic sialylated glycoconjugates Can J Microbiol 37 233 237
21. Z Gan R Roy 2000 Facile preparation of divalent sialoside derivatives by olefin metathesis reaction Tetrahedron 56 1423 1428 10.1016/S0040-4020(00)00034- X
22. Q Ge MT McManus T Nguyen CH Shen PA Sharp HN Eisen J Chen 2003 RNA interference of infl uenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription Proc Natl Acad Sci USA 100 2718 2723 10.1073/pnas.0437841100
23. Q Ge HN Eisen J Chen 2004 Use of siRNAs to prevent and treat influenza virus infection Virus Res 102 37 42 10.1016/j.virusres.2004.01.013
24. GD Glick PL Toogood DC Wiley JJ Skehel JR Knowles 1991 Ligand recognition by influenza virus: the binding of bivalent sialosides J Biol Chem 266 23660 23669
25. EA Govorkova HB Fang M Tan RG Webster 2004 Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells Antimicrob Agents Chemother 48 12 4855 4863 10.1128/AAC.48.12.4855-4863.2004
26. CT Guo XL Sun O Kanie KF Shortridge T Suzuki D Miyamoto KIP Jwa Hidari CH Wong Y Suzuki 2002 An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses Glycobiology 12 183 190 10.1093/glycob/12.3.183 (Pubitemid 34567864)
27. FG Hayden 2006 Antivirals for influenza: historical perspectives and lessons learned Antiviral Res 71 372 378 10.1016/j.antiviral.2006.05.016
28. FG Hayden RB Belshe RD Clover AJ Hay MG Oakes W Soo 1989 Emergence and apparent transmission of rimantadine-resistant influenza A virus in families N Engl J Med 321 1696 1702 (Pubitemid 20020544)
29. HP Hsieh JTA Hsu 2007 Strategies of development of antiviral agents directed against influenza virus replication Curr Pharm Des 13 34 3531 3542 10.2174/138161207782794248
30. M Itoh P Hetterich R Isecke R Brossmer HD Klenk 1995 Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase Virology 212 340 347 10.1006/viro.1995.1491
31. H Kamitakahara T Suzuki N Nishigori Y Suzuki O Kanie CH Wong 1998 A lysoganglioside/poly-l-glutamic acid conjugate as a picomolar inhibitor of influenza hemagglutinin Angew Chem Int Ed 11 1524 1528 10.1002/(SICI)1521- 3773(19980619)37:11<1524::AID-ANIE1524>3.0.CO;2-D
32. MJ Kiefel M von Itztein 2002 Recent advances in the synthesis of sialic acid derivatives and sialylmimetics as biological probes Chem Rev 102 471 490 10.1021/cr000414a
33. Kiessling LL, Strong LE, Gestwicki JE (2000) Chapter 29. Principles for multivalent ligand design. Ann Rep Med Chem 35:321-330
34. JE Kingery-Wood KW Williams GG Sigal GM Whitesides 1992 The agglutination of erythrocytes by influenza virus is strongly inhibited by liposomes incorporating an analog of sialyl gangliosides J Am Chem Soc 114 7303 7305 10.1021/ja00044a057
35. IM Lagoja E De Clercq 2008 Anti-influenza virus agents: synthesis and mode of action Med Res Rev 28 1 1 38 10.1002/med.20096
36. Lamb RA, Krug RM (2001) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fundamental virology. Lippincott Williams & Wilkins, Philadelphia, pp 725-770
37. Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker J, Jr R (2002) Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers. J Infect Dis 186(9):1222-1230. doi: 10.1086/344316
38. WJ Lees A Spaltenstein JE Kingery-Wood GM Whitesides 1994 Polyacrylamides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A virus: multivalency and steric stabilization of particulate biological systems J Med Chem 37 3419 3433 10.1021/jm00046a027
39. Y Ma CY Chan ML He 2007 RNA interference and antiviral therapy World J Gastroenterol 13 39 5169 5179 (Pubitemid 47532893)
40. Y Makimura S Watanabe T Suzuki Y Suzuki H Ishida M Kiso T Katayama H Kumagai K Yamamoto 2006 Chemoenzymatic synthesis and application of a sialoglycopolymer with a chitosan backbone as a potent inhibitor of human influenza virus hemagglutination Carbohydr Res 341 11 1803 1808 10.1016/j.carres.2006.04.024
41. M Mammen G Dahmann GM Whitesides 1995 Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition J Med Chem 38 21 4179 4190 10.1021/jm00021a007
42. M Mammen SK Choi GM Whitesides 1998 Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew Chem Int Ed 37 2755 2794 10.1002/(SICI)1521-3773(19981102)37:20<2754:: AID-ANIE2754>3.0.CO;2-3
43. A Marra L Moni D Pazzi A Corallini D Bridi A Dondoni 2008 Synthesis of sialoclusters appended to calix[4]arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemagglutination and cytopathic effect mediated by BK and influenza A viruses Org Biomol Chem 6 1396 1409 10.1039/b800598b
44. MN Matrosovich 1989 Towards the development of antimicrobial drugs acting by inhibition of pathogen attachment to host cells: a need for polyvalency FEBS Lett 252 1 4 10.1016/0014-5793(89)80879-8
45. M Matrosovich HD Klenk 2003 Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding Rev Med Virol 13 2 85 97 10.1002/rmv.372
46. MN Matrosovich LV Mochalova VP Marinina NE Byramova NV Bovin 1990 Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity FEBS Lett 272 209 212 10.1016/0014-5793(90)80486-3
47. JA McSwiggen S Seth 2008 A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A Expert Opin Biol Ther 8 3 299 313 10.1517/14712598.8.3.299
48. LV Mochalova AB Tuzikov VP Marinina 1994 Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication Antiviral Res 23 179 190 10.1016/0166-3542(94)90016-7 (Pubitemid 24122296)
49. P Niederhafner M Reinis J Šebestik J Jezek 2008 Glycopeptide dendrimers, part III-a review: use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases J Pept Sci 14 5 556 587 10.1002/psc.1011
50. M Ogata T Murata K Murakami T Suzuki KIPJ Hidari Y Suzuki T Usui 2007 Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a γ-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses Bioorg Med Chem 15 1383 1393 10.1016/j.bmc.2006.11.006
51. H Oka T Onaga T Koyama CT Guo Y Suzuki Y Esumi K Hatano D Terunuma K Matsuoka 2008 Sialyl α(2 → 3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers Bioorg Med Chem Lett 18 15 4405 4408 10.1016/j.bmcl.2008.06.101
52. LJ Prins DN Reinhoudt P Timmerman 2001 Noncovalent synthesis using hydrogen bonding Angew Chem Int Ed 40 13 2382 2426 10.1002/1521-3773(20010702) 40:13<2382::AID-ANIE2382>3.0.CO;2-G
53. TJ Pritchett JC Paulson 1989 Basis for the potent inhibition of influenza virus infection by equine and guinea pig α2-macroglobulin J Biol Chem 264 9850 9858 (Pubitemid 19159249)
54. A Reichert JO Nagy W Spevak D Charych 1995 Polydiacetylene liposomes functionalized with sialic acid bind and colorimetrically detect influenza virus J Am Chem Soc 117 829 830 10.1021/ja00107a032
55. JD Reuter A Myc MM Hayes Z Ga R Roy D Qin R Yin LT Piehler R Esfand DA Tomalia JR Baker Jr 1999 Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers Bioconjug Chem 10 271 278 10.1021/bc980099n
56. C Rohm N Zhou J Suss J Mackenzie RG Webster 1996 Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes Virology 217 2 508 516 10.1006/viro.1996.0145
57. R Roy FO Andersson G Harms S Kelm R Schauer 1992 Synthesis of esterase-resistant 9-O-acetylated polysialoside as inhibitor of influenza C virus hemagglutinin Angew Chem Int Ed Engl 31 1478 1481 10.1002/anie.199214781
58. Roy R, Zanini D, Meunier SJ, Romanowska A (1993) Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin. J Chem Soc Chem Commun 1869-1872. doi: 10.1039/c39930001869 (Pubitemid 24026734)
59. JI Sakamoto T Koyama D Miyamoto S Yingsakmongkon KIPJ Hidari W Jampangern T Suzuki Y Suzuki Y Esumi K Hatano D Terunuma K Matsuoka 2007 Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors Bioorg Med Chem Lett 17 3 717 721 10.1016/j.bmcl.2006. 10.085
60. Sashiwa H, Makimura Y, Shigemasa Y, Roy R (2000a) Chemical modification of chitosan: preparation of chitosan-sialic acid branched polysaccharide hybrids. Chem Commun 909-910 (Pubitemid 30389936)
61. H Sashiwa Y Shigemasa R Roy 2000 Chemical modification of chitosan. 3. Hyperbranched chitosan-sialic acid dendrimer hybrid with tetraethylene glycol spacer Macromolecules 33 6913 6915 10.1021/ma0005769
62. H Sashiwa Y Shigemasa R Roy 2001 Highly convergent synthesis of dendrimerized chitosan-sialic acid hybrid Macromolecules 34 3211 3214 (Pubitemid 34216940)
63. H Sashiwa Y Shigemasa R Roy 2001 Chemical modification of chitosan. 10.1 Synthesis of dendronized chitosan-sialic acid hybrid using convergent grafting of preassembled dendrons built on gallic acid and tri(ethylene glycol) backbone Macromolecules 34 3905 3909 10.1021/ma001832k
64. H Sashiwa Y Shigemasa R Roy 2002 Chemical modification of chitosan. Part 9: reaction of N-carboxyethylchitosan methyl ester with diamines of acetal ending PAMAM dendrimers Carbohydr Polym 47 201 208 (Pubitemid 33018661)
65. H Sashiwa Y Shigemasa R Roy 2002 Chemical modification of chitosan 11: chitosan-dendrimer hybrid as a tree like molecule Carbohydr Polym 49 195 205 (Pubitemid 34410794)
66. H Sashiwa Y Shigemasa R Roy 2002 Chemical modification of chitosan 8: preparation of chitosan-dendrimer hybrids via short spacer Carbohydr Polym 47 191 199 10.1016/S0144-8617(01)00166-7
67. GB Sigal M Mammen G Dahmann GM Whitesides 1996 Polyacrylamides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: the strong inhibition reflects enhanced binding through cooperative polyvalent interactions J Am Chem Soc 118 16 3789 3800 10.1021/ja953729u
68. JJ Skehel DC Wiley 2000 Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin Annu Rev Biochem 69 531 569 10.1146/annurev.biochem.69.1.531
69. A Spaltenstein GM Whitesides 1991 Polyacrylamides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus J Am Chem Soc 113 686 687 10.1021/ja00002a053
70. MA Sparks KW Williams GM Whitesides 1993 Neuraminidase-resistant hemagglutination inhibitors: acrylamide copolymers containing a C-glycoside of N-acetylneuraminic acid J Med Chem 36 778 783 10.1021/jm00058a016 (Pubitemid 23105733)
71. W Spevak JO Nagy DH Charych ME Schaefer JH Gilbert MD Bednarski 1993 Polymerized liposomes containing C-glycosides of sialic acid: potent inhibitors of influenza virus in vitro infectivity J Am Chem Soc 115 146 1147 10.1021/ja00056a047
72. JC Stoof J Booij B Drukarch EC Wolters 1992 The anti-parkinsonian drug amantadine inhibits the N-methyl-d-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way Eur J Pharmacol 213 439 443 10.1016/0014-2999(92)90634-G
73. Sun XL, Kanie Y, Guo CT, Kanie O, Suzuki Y, Wong CH (2000) Syntheses of C-3-modified sialylglycosides as selective inhibitors of influenza hemagglutinin and neuraminidase. Eur J Org Chem 2643-2653. doi:10.1002/1099-0690(200007)2000: 14<2643::AID-EJOC2643>3.0.CO;2-1
74. Y Suzuki 1994 Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains Prog Lipid Res 33 429 457 10.1016/0163-7827(94)90026-4
75. SM Tompkins CY Lo TM Tumpey SL Epstein 2004 Protection against lethal infl uenza virus challenge by RNA interference in vivo Proc Natl Acad Sci USA 101 8682 8686 10.1073/pnas.0402630101
76. K Totani T Kubota T Kuroda T Murata KIP Jwa Hidari T Suzuki Y Suzuki K Kobayashi H Ashida K Yamamoto T Usui 2003 Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(l-glutamic acid) backbone for inhibition of infection by influenza viruses Glycobiology 13 5 315 326 10.1093/glycob/cwg032
77. JJ Treanor FG Hayden PS Vrooman R Barbarash R Bettis D Riff S Singh N Kinnersley P Ward RG Mills 2000 Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza JAMA 283 8 1016 1024 10.1001/jama.283.8.1016
78. A Tsuchida K Kobayashi N Matsubara T Muramatsu T Suzuki Y Suzuki 1998 Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus Glycoconj J 15 1047 1054 10.1023/A:1006960116583
79. DE Tsvetkov PE Cheshev AB Tuzikov AA Chinarev GV Pazynina MA Sablina AS Gambaryan NV Bovin R Rieben AS Shashkov NE Nifant'ev 2002 Neoglycoconjugates based on dendrimer poly(aminoamides) Russ J Bioorganic Chem 28 6 470 486 10.1023/A:1021293532046
80. AB Tuzikov NE Byramova NV Bovin AS Gambaryan MN Matrosovich 1997 Monovalent and polymeric 5 N-thioacetamido sialosides as tightly-bound receptor analogs of influenza viruses Antiviral Res 33 129 134 10.1016/S0166-3542(96) 00998-9
81. AB Tuzikov AS Gambaryan LR Juneja NV Bovin 2000 Conversion of complex sialooligosaccharides into polymeric conjugates and their anti-influenza virus inhibitory potency J Carbohydr Chem 19 9 1191 1200 10.1080/07328300008544143 (Pubitemid 33209690)
82. A Tuzikov A Chinarev A Gambaryan V Oleinikov D Klinov N Matsko V Kadykov M Ermishov I Demin V Demin P Rye N Bovin 2003 Polyglycine II nanosheets: supramolecular antivirals? ChemBioChem 4 147 154 10.1002/cbic.200390025 (Pubitemid 36343169)
83. JN Varghese 1999 Development of neuraminidase inhibitors as anti-influenza virus drugs Drug Dev Res 46 3-4 176 196 10.1002/(SICI)1098- 2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6
84. JN Varghese WG Laver PM Colman 1983 Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution Nature 303 35 40 10.1038/303035a0
85. M von Itzstein WY Wu GB Kok MS Pegg JC Dyason B Jin TV Phan ML Smythe HF White SW Oliver 1993 Rational design of potent sialidase-based inhibitors of influenza virus replication Nature 363 418 423 10.1038/363418a0
86. SJ Watowich JJ Skehel DC Wiley 1994 Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs Structure 2 719 731 10.1016/S0969-2126(00)00073-3
87. RG Webster WJ Bean OT Gorman TM Chambers Y Kawaoka 1992 Evolution and ecology of influenza A viruses Microbiol Rev 56 1 152 179
88. W Weiss JH Brown S Cusack JC Paulson JJ Skehel DC Wiley 1988 Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid Nature 333 2 426 431 10.1038/333426a0
89. GM Whitesides JP Mathias CT Seto 1991 Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures Science 254 5036 1312 1319 10.1126/science.1962191 (Pubitemid 21917458)
90. DC Wiley JJ Skehel 1987 The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu Rev Biochem 56 365 394 10.1146/annurev.bi.56.070187.002053
91. DC Wiley IA Wilson JJ Skehel 1981 Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation Nature 289 373 378 10.1038/289373a0
92. IA Wilson JJ Skehel DC Wiley 1981 Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution Nature 289 5796 366 373 10.1038/289366a0